A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: A prospective cohort study

Haematologica

Volumn 92, Issue 2, 2007, Pages

  Kuhle, Stefan ^a,b   Eulmesekian, Pablo ^a   Kavanagh, Brian ^a   Massicotte, Patricia ^b   Vegh, Patricia ^a   Mitchell, Lesley G ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c STOLLERY CHILDREN S HOSPITAL   (Canada)

Author keywords

Bleeding; Children; Unfractionated heparin

Indexed keywords

HEPARIN; ANTICOAGULANT AGENT; HEMOGLOBIN;

ADOLESCENT; ARTICLE; BLEEDING; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; NEWBORN; PROPHYLAXIS; VEIN THROMBOSIS; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; PRESCHOOL CHILD; PROSPECTIVE STUDY; THROMBOSIS; TREATMENT OUTCOME;

ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMOGLOBINS; HEMORRHAGE; HEPARIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; THROMBOSIS; TREATMENT OUTCOME;

EID: 33947495545     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10616     Document Type: Article

References (11)

1. Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:645S-87S.
2. Andrew M, Mitchell L, Vegh P, Ofosu F. Thrombin regulation in children differs from adults in the absence and presence of heparin. Thromb Haemost 1994;72:836-42.
3. Schmidt B, Ofosu FA, Mitchell L, Brooker LA, Andrew M. Anticoagulant effects of heparin in neonatal plasma. Pediatr Res 1989; 25:405-8.
4. Vieira A, Berry L, Ofosu F, Andrew M. Heparin sensitivity and resistance in the neonate: an explanation. Thromb Res 1991;63:85-98.
5. Andrew M, Ofosu F, Schmidt B, Brooker L, Hirsh J, Buchanan MR. Heparin clearance and ex vivo recovery in newborn piglets and adult pigs. Thromb Res 1988;52: 517-27.
6. Andrew M, Marzinotto V, Massicotte P, et al. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res 1994; 35: 78-83.
7. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999;130:800-9.
8. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994;83:1251-7.
9. Manco-Johnson MJ, Nuss R, Hays T, Krupski W, Drose J, Manco-Johnson ML. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr 2000;136:446-53.
10. Mitchell L, Kuhle S, Massicotte PM, Vegh P. Increase incidence of major bleeding in children receiving unfractionated heparin for clinical management: a prospective cohort study. Blood 2004;104:1772A.
11. Ignjatovic V, Summerhayes R, Than J, Gan A, Monagle P. Therapeutic range for unfractionated heparin (UFH) therapy: age-related differences in response in children. J Thromb Haemost. 2006 (in press)